Photocure ASA: Annual accounts

Oslo, 6 April 2016: Photocure ASA (OSE: PHO), has published the annual
accounts and annual report for the financial year 2015.

The annual accounts and annual report for the financial year 2015 are enclosed
with this notification and made available on the company's
website,www.photocure.com.

For further information, please contact:
Photocure
CFO Erik Dahl
Tel: +47 450 55 000, Email:ed@photocure.no

About Photocure ASA

Photocure, headquartered in Oslo Norway, is a specialty pharmaceutical company
and world leader in photodynamic technology. Based on our unique proprietary
Photocure Technology(TM) platform, Photocure develops and commercializes
highly selective and effective solutions within disease areas with high unmet
medical need, such as bladder cancer, HPV and precancerous cervical lesions,
colorectal cancer and skin conditions. Our aim is to provide solutions which
can improve health outcomes for patients worldwide. Photocure is listed on
the Oslo Stock Exchange (OSE: PHO). Information about Photocure is available
atwww.photocure.com.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

Annual report 2015
http://hugin.info/131151/R/2001300/738352.pdf

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Photocure ASA via Globenewswire

HUG#2001300